Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03690427 · ClinicalTrials.gov registry record · NA

The Cardiovascular Effects of Electronic Hookah Vaping

A NA study, sponsored by University of California, Los Angeles.

Completed
Registry status
NA
Development phase
19
Enrollment target

NCT03690427 is a NA study that has completed, run by University of California, Los Angeles. The registered enrollment target is 19 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03690427, a NA study, has completed, sponsored by University of California, Los Angeles.

COMPLETED
Registry status
NA
Development phase
19 participants
Enrollment target

Study Summary

Hookah (water-pipe) tobacco smoking has quickly grown to become a major global tobacco epidemic among youth; with electronic (e-) hookahs more recently increasing in popularity especially among young female adults, who endorse marketing claims that these products are a safer alternative to traditional hookah, but scientific evidence is lacking. The study aims to elucidate the comparative effects of traditional hookah smoking vs. e-hookah vaping on human vascular and endothelial function; and examine the role of inflammation and oxidative stress, as likely mechanisms in hookah-related cardiovascular disease pathogenesis.

Interventions

  • OTHER Traditional hookah smoking
  • OTHER Electronic hookah vaping

Trial Details

FieldValue
Enrollment Target 19 participants
Start Date 2018-12-11
Est. Completion 2021-09-27
Phase NA

What the Registry Record Tells You About NCT03690427

The ClinicalTrials.gov registry entry for NCT03690427 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 19 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, Los Angeles, which has 897 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which Traditional hookah smoking is the first listed.

NCT03690427 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT03690427 about?

NCT03690427 is a clinical study titled "The Cardiovascular Effects of Electronic Hookah Vaping". Hookah (water-pipe) tobacco smoking has quickly grown to become a major global tobacco epidemic among youth; with electronic (e-) hookahs more recently increasing in popularity especially among young female adults, who endorse marketing claims that these products are a safer alternative to tradition...

What is the current status of trial NCT03690427?

This trial is currently completed. It is a NA study. The enrollment target is 19 participants. The study started on 2018-12-11. Estimated completion is 2021-09-27.

What interventions are being tested in trial NCT03690427?

The interventions under investigation include: Traditional hookah smoking (OTHER), Electronic hookah vaping (OTHER).

Who is sponsoring clinical trial NCT03690427?

This trial is sponsored by University of California, Los Angeles, which has 897 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.